Siddiqui says the study showed that the rapid antigen test was high in sensitivity (ability to identify people for whom the PCR test would detect a SARS-CoV-2 infection) at 92.7% for all ...

Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.

As the need for rapid diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases, due to the relentless surge in coronavirus disease 2019 (COVID-19) cases ...

Basel, 01 February 2021- Roche today announced it has obtained the CE mark for its new SARS-CoV-2 Rapid Antigen Test Nasal. Whether the test could also be used without supervision of a healthcare ...

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests. Cell , 2022; 185 (19): 3603 DOI: 10.1016/j.cell.2022.08.010 Cite This Page : ...

Basel, 1 September 2020- Roche announced today that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark. Roche also intends to file for Emergency ...

The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on ...

With rapid antigen tests for SARS-CoV-2 slow to come to market, officials at the US Food and Drug Administration have tried to signal via a number of public comments that the agency would be ...

TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world ...

LONDON, Oct. 15, 2021 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostic company, today announced it has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the ...

Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening.